Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients

BACKGROUND: This study aims to better define prognostic factors for patients with metastatic urothelial carcinoma (mUC), and to identify patients who will benefit from first-line cisplatin-based chemotherapy. We test the hypothesis that early objective response (EOR), defined as the occurrence of an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Negat Results Biomed
Main Authors: Roubaud, Guilhem, Brouste, Véronique, Beuzeboc, Phillipe, Fléchon, Aude, Tosi, Diego, Lavau-Denes, Sandrine, Chevreau, Christine, Culine, Stéphane, Oudard, Stéphane, Quivy, Amandine, Pourquier, Philippe, Houédé, Nadine
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641378/
https://ncbi.nlm.nih.gov/pubmed/26555878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12952-015-0037-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados